Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Rivka Yatuv, Micah Robinson, Inbal Dayan-Tarshish & Moshe Baru. (2010) The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia. International Journal of Nanomedicine 5, pages 581-591.
Read now
Read now
Rivka Yatuv, Micah Robinson, Inbal Dayan & Moshe Baru. (2010) Enhancement of the efficacy of therapeutic proteins by formulation with PEGylated liposomes; a case of FVIII, FVIIa and G-CSF. Expert Opinion on Drug Delivery 7:2, pages 187-201.
Read now
Read now
Articles from other publishers (21)
Joanna Grabowska, Valentine Léopold, Katarzyna Olesek, Maarten K. Nijen Twilhaar, Alsya J. Affandi, Mieke C. Brouwer, Ilse Jongerius, Admar Verschoor, Cees van Kooten, Yvette van Kooyk, Gert Storm, Cornelis van ‘t Veer & Joke M. M. den Haan. (2023) Platelets interact with CD169+ macrophages and cDC1 and enhance liposome-induced CD8+ T cell responses. Frontiers in Immunology 14.
Crossref
Crossref
Tahereh Zadeh Mehrizi. (2022) Assessment of the effect of polymeric nanoparticles on storage and stability of blood products (red blood cells, plasma, and platelet). Polymer Bulletin 80:3, pages 2263-2298.
Crossref
Crossref
Huong D.N. Tran, Fahima Akther, Zhi Ping Xu & Hang T. Ta. 2022. Nanotechnology for Hematology, Blood Transfusion, and Artificial Blood. Nanotechnology for Hematology, Blood Transfusion, and Artificial Blood
113
140
.
Huong D. N. Tran, Shehzahdi Shebbrin Moonshi, Zhi Ping Xu & Hang Thu Ta. (2022) Influence of nanoparticles on the haemostatic balance: between thrombosis and haemorrhage. Biomaterials Science 10:1, pages 10-50.
Crossref
Crossref
Yih Rue Ong, Robert De Rose & Angus P. R. Johnston. (2021) In Vivo Quantification of Nanoparticle Association with Immune Cell Subsets in Blood. Advanced Healthcare Materials 10:9.
Crossref
Crossref
Patrick M. Glassman & Vladimir R. Muzykantov. (2019) Pharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems. Journal of Pharmacology and Experimental Therapeutics 370:3, pages 570-580.
Crossref
Crossref
María Francisca Matus, Cristian Vilos, Bruno A. Cisterna, Eduardo Fuentes & Iván Palomo. (2018) Nanotechnology and primary hemostasis: Differential effects of nanoparticles on platelet responses. Vascular Pharmacology 101, pages 1-8.
Crossref
Crossref
Manohar Mahato, Giridhara R. Jayandharan & Praveen Kumar Vemula. 2018. Gene and Cell Therapy: Biology and Applications. Gene and Cell Therapy: Biology and Applications
111
130
.
Jan Simak & Silvia De Paoli. (2017) The effects of nanomaterials on blood coagulation in hemostasis and thrombosis. WIREs Nanomedicine and Nanobiotechnology 9:5.
Crossref
Crossref
Simone Esposito, Sonia Colicchia, Xavier de la Torre, Francesco Donati, Monica Mazzarino & Francesco Botrè. (2017) Liposomes as potential masking agents in sport doping. Part 2: Detection of liposome-entrapped haemoglobin by flow cytofluorimetry. Drug Testing and Analysis 9:2, pages 208-215.
Crossref
Crossref
Silvia Lorenzo-Abalde, Rosana Simón-Vázquez, Mercedes Peleteiro Olmedo, Tamara Lozano-Fernández, Olivia Estévez-Martínez, Andrea Fernández-Carrera & África González-Fernández. 2016. Polymer Nanoparticles for Nanomedicines. Polymer Nanoparticles for Nanomedicines
221
289
.
Anju Gupta, Reetu Gupta & Sudarshan Kurwardkar. 2015. Handbook of Research on Diverse Applications of Nanotechnology in Biomedicine, Chemistry, and Engineering. Handbook of Research on Diverse Applications of Nanotechnology in Biomedicine, Chemistry, and Engineering
301
332
.
Anna N Ilinskaya & Marina A Dobrovolskaia. (2013) Nanoparticles and the blood coagulation system. Part II: safety concerns. Nanomedicine 8:6, pages 969-981.
Crossref
Crossref
Junliang Pan, Tongyao Liu, Ji-Yun Kim, Daguang Zhu, Chandra Patel, Zhi-Hua Cui, Xin Zhang, James O. Newgren, Aaron Reames, Dodie Canivel, Gary Jesmok, Glenn F. Pierce, Jurg M. Sommer & Haiyan Jiang. (2009) Enhanced efficacy of recombinant FVIII in noncovalent complex with PEGylated liposome in hemophilia A mice. Blood 114:13, pages 2802-2811.
Crossref
Crossref
I. DAYAN, M. ROBINSON & M. BARU. (2009) Enhancement of haemostatic efficacy of plasma-derived FVIII by formulation with PEGylated liposomes. Haemophilia 15:5, pages 1006-1013.
Crossref
Crossref
Jan Simak. 2009. Nanotoxicity. Nanotoxicity
191
225
.
Rivka Yatuv, Lea Carmel-Goren, Inbal Dayan, Micah Robinson & Moshe Baru. (2009) Binding of proteins to PEGylated liposomes and improvement of G-CSF efficacy in mobilization of hematopoietic stem cells. Journal of Controlled Release 135:1, pages 44-50.
Crossref
Crossref
Kim S. Horger, Daniel J. Estes, Ricardo Capone & Michael Mayer. (2009) Films of Agarose Enable Rapid Formation of Giant Liposomes in Solutions of Physiologic Ionic Strength. Journal of the American Chemical Society 131:5, pages 1810-1819.
Crossref
Crossref
Jelena L. HolovatiMaria I.C. Gyongyossy-IssaJason P. Acker. (2008) Effect of Liposome Charge and Composition on the Delivery of Trehalose into Red Blood Cells. Cell Preservation Technology 6:3, pages 207-218.
Crossref
Crossref
Jelena L. HolovatiMaria I.C. Gyongyossy-IssaJason P. Acker. (2008) Investigating Interactions of Trehalose-Containing Liposomes with Human Red Blood Cells. Cell Preservation Technology 6:2, pages 133-146.
Crossref
Crossref
J. M. Koziara, J. J. Oh, W. S. Akers, S. P. Ferraris & R. J. Mumper. (2005) Blood Compatibility of Cetyl Alcohol/Polysorbate-Based Nanoparticles. Pharmaceutical Research 22:11, pages 1821-1828.
Crossref
Crossref